Dotbio
Blood & Organ Banks · Singapore · 11-50 Employees
View Company Info for Free
Overview
Headquarters
SingaporePhone Number
+65 69060743Website
www.dotbiopharma.comRevenue
<$5 MillionIndustry
About Dotbio
DotBio is a biopharmaceutical company that specializes in next-generation domain antibody therapies. Utilizing its proprietary DotBody technology platform, the company creates multi-functional and intracellular antibody therapies derived from stabilized human VH domains. DotBio's innovative approach allows for the rapid generation of bi- and tri-specific antibodies, antibody-drug conjugates, and intracellular antibodies. The company aims to provide advanced therapeutic solutions for various medical needs.Explore more
SIC Code 28,283NAICS Code 32,325Show more
Dotbio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Dotbio Tech Stack
A closer look at the technologies used by Dotbio
Top Blood & Organ Banks Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Dotbio
Sign Up For FreeTo access detailed company insights
DotBio is a biopharmaceutical company that specializes in next-generation domain antibody therapies. Utilizing its proprietary DotBody technology platform, the company creates multi-functional and intracellular antibody therapies derived from stabilized human VH domains. DotBio's innovative approach allows for the rapid generation of bi- and tri-sp... Read More
